share_log

Insider Buys Additional HK$589k In Clarity Medical Group Holding Stock \

Insider Buys Additional HK$589k In Clarity Medical Group Holding Stock \

內幕人士額外購買了5.89萬港元的Clarity Medical Group控股
Simply Wall St ·  2023/05/06 06:23

Whilst it may not be a huge deal, we thought it was good to see that the Clarity Medical Group Holding Limited (HKG:1406) Executive Director, Wai Ip Tse, recently bought HK$589k worth of stock, for HK$1.19 per share. Nevertheless, it only increased their shareholding by a minuscule percentage, and it wasn't a massive purchase by absolute value, either.

雖然這可能不是甚麼大問題,但我們認爲很高興看到 清晰醫療集團控股有限公司 (HKG: 1406) 執行董事謝偉業最近以每股1.19港元的價格購買了價值58.9萬港元的股票。儘管如此,這隻使他們的持股量增加了微不足道的百分比,而且按絕對價值計算,這也不是一次大規模收購。

Check out our latest analysis for Clarity Medical Group Holding

查看我們對Clarity醫療集團控股的最新分析

The Last 12 Months Of Insider Transactions At Clarity Medical Group Holding

Clarity 醫療集團控股公司過去 12 個月的內幕交易

Notably, that recent purchase by Executive Director Wai Ip Tse was not the only time they bought Clarity Medical Group Holding shares this year. They previously made an even bigger purchase of HK$735k worth of shares at a price of HK$1.47 per share. That means that even when the share price was higher than HK$1.20 (the recent price), an insider wanted to purchase shares. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. To us, it's very important to consider the price insiders pay for shares. As a general rule, we feel more positive about a stock when an insider has bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. Wai Ip Tse was the only individual insider to buy shares in the last twelve months.

值得注意的是,執行董事謝偉業最近的收購併不是他們今年唯一一次購買Clarity Medical Group Holding的股票。他們此前以每股1.47港元的價格購買了價值73.5萬港元的股票。這意味着,即使股價高於1.20港元(最近的價格),內部人士也想購買股票。儘管自收購以來他們的看法可能發生了變化,但這至少表明他們對公司的未來充滿信心。對我們來說,考慮內部人士爲股票支付的價格非常重要。一般而言,當內部人士以高於當前價格購買股票時,我們對股票的看法更爲樂觀,因爲這表明他們認爲該股票即使價格更高,也具有良好的價值。謝偉業是過去十二個月中唯一一位買入股票的內部人士。

Wai Ip Tse bought 1.94m shares over the last 12 months at an average price of HK$1.24. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

謝偉業在過去12個月中以1.24港元的平均價格購買了194萬股股票。下圖顯示了去年的內幕交易(公司和個人)。如果您想確切知道誰賣了、賣了多少錢、何時出售,只需點擊下面的圖表即可!

insider-trading-volume
SEHK:1406 Insider Trading Volume May 5th 2023
SEHK: 1406 2023 年 5 月 5 日內幕交易量

Clarity Medical Group Holding is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Clarity Medical Group Holding並不是內部人士唯一購買的股票所以看看這個 免費的 有內幕收購的成長型公司名單。

Insider Ownership Of Clarity Medical Group Holding

Clarity 醫療集團控股的內部所有權

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 23% of Clarity Medical Group Holding shares, worth about HK$144m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

查看一家公司的內部持股總額可以幫助您瞭解他們是否與普通股股東保持一致。較高的內部所有權通常會使公司領導層更加關注股東的利益。內部人士擁有Clarity Medical Group Holding23%的股份,價值約1.44億港元。當然,我們已經看到其他地方的內部所有權水平有所提高,但這些持股足以表明內部人士與其他股東之間存在一致性。

What Might The Insider Transactions At Clarity Medical Group Holding Tell Us?

Clarity 醫療集團控股的內幕交易會告訴我們甚麼?

The recent insider purchase is heartening. We also take confidence from the longer term picture of insider transactions. When combined with notable insider ownership, these factors suggest Clarity Medical Group Holding insiders are well aligned, and quite possibly think the share price is too low. Nice! So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. Be aware that Clarity Medical Group Holding is showing 5 warning signs in our investment analysis, and 1 of those shouldn't be ignored...

最近的內幕收購令人振奮。我們還從內幕交易的長期前景中獲得信心。再加上顯著的內部所有權,這些因素表明Clarity Medical Group Holding的內部人士非常一致,很可能認爲股價太低了。不錯!因此,雖然瞭解內部人士在買入或賣出方面的所作所爲很有幫助,但瞭解特定公司面臨的風險也很有幫助。請注意 Clarity Medical Group Holdin 我們的投資分析中有5個警告信號,其中 1 個不容忽視...

But note: Clarity Medical Group Holding may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

但請注意: Clarity Medical Group Holding 可能不是最值得買入。所以來看看這個 免費的 投資回報率高、負債低的有趣公司名單。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

就本文而言,內部人士是指向相關監管機構報告交易的個人。我們目前用於公開市場交易和私人處置,但不包括衍生品交易。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?擔心內容嗎? 取得聯繫 直接和我們在一起。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St 的這篇文章本質上是籠統的。 我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。 它不構成買入或賣出任何股票的建議,也沒有考慮您的目標或財務狀況。我們的目標是爲您提供由基本面數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。簡而言之,華爾街在上述任何股票中都沒有頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論